# Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer

> **NCT01566240** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **University College, London** · enrollment: 500 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Carboplatin
- **RADIATION:** Radiotherapy
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01566240
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2012-11-08
- **Primary completion:** 2026-02
- **Final completion:** 2026-12
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2024-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01566240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01566240, "Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01566240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*